| Kilitch Drugs (India) Ltd | Industry : (Pharmaceuticals) | |
|---|---|---|
|
BSE Code : 524500 |
NSE Symbol : KILITCH |
P/E(TTM) : 20.32 |
|
ISIN Demat : INE729D01010 |
Div & Yield% : 0.00 |
EPS(TTM) : 9.27 |
|
Book Value(₹) : 95.25 |
Market Cap(₹Cr) : 658.68 |
Face Value(₹) : 10.00 |
| Particulars | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
|---|---|---|---|---|---|---|
| Gross Sales | 71.97 | 44.67 | 37.81 | 34.12 | 56.30 | 46.51 |
| Excise Duty | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Net Sales | 71.97 | 44.67 | 37.81 | 34.12 | 56.30 | 46.51 |
| Other Operating Income | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Other Income | 1.14 | 1.61 | 7.61 | 3.50 | 2.32 | 2.37 |
| Total Income | 73.11 | 46.28 | 45.42 | 37.62 | 58.63 | 48.88 |
| Total Expenditure | 52.50 | 38.95 | 34.14 | 30.55 | 42.40 | 38.40 |
| PBIDT | 20.61 | 7.33 | 11.28 | 7.07 | 16.23 | 10.49 |
| Interest | 0.58 | 0.60 | 0.68 | 0.59 | 0.72 | 0.49 |
| PBDT | 20.03 | 6.73 | 10.60 | 6.48 | 15.51 | 9.99 |
| Depreciation | 0.70 | 0.56 | 0.53 | 0.50 | 0.51 | 0.47 |
| Tax | 6.18 | 1.60 | 1.78 | 1.30 | 3.56 | 2.87 |
| Fringe Benefit Tax | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Deferred Tax | -0.85 | -0.32 | -0.42 | -0.11 | 0.07 | -0.23 |
| Reported Profit After Tax | 14.00 | 4.89 | 8.72 | 4.79 | 11.37 | 6.88 |
| Extra-ordinary Items | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Adjusted Profit After Extra-ordinary item | 14.00 | 4.89 | 8.72 | 4.79 | 11.37 | 6.88 |
| EPS (Unit Curr.) | 4.08 | 2.74 | 5.27 | 2.98 | 7.07 | 4.28 |
| EPS (Adj) (Unit Curr.) | 4.08 | 1.37 | 2.64 | 1.46 | 3.46 | 2.09 |
| Calculated EPS (Unit Curr.) | 4.00 | 2.80 | 4.99 | 2.98 | 7.07 | 4.28 |
| Calculated EPS (Adj) (Unit Curr.) | 4.00 | 1.40 | 2.50 | 1.46 | 3.46 | 2.09 |
| Calculated EPS (Ann.) (Unit Curr.) | 16.02 | 11.19 | 19.94 | 11.92 | 28.29 | 17.12 |
| Calculated EPS (Adj) (Ann.) (Unit Curr.) | 16.02 | 5.60 | 9.97 | 5.83 | 13.84 | 8.38 |
| Book Value (Unit Curr.) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Dividend (%) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Equity | 34.96 | 17.48 | 17.48 | 16.08 | 16.08 | 16.08 |
| Reserve & Surplus | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Face Value | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Public Shareholding (No. Of Shares) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Public Shareholding (% in Equity) | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Pledged/Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - No. of Shares | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Promoters Holding | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Non Encumbered - % in Total Equity | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| PBIDTM(%) | 28.64 | 16.41 | 29.83 | 20.72 | 28.83 | 22.55 |
| PBDTM(%) | 27.83 | 15.07 | 28.03 | 18.99 | 27.55 | 21.48 |
| PATM(%) | 19.45 | 10.95 | 23.06 | 14.04 | 20.20 | 14.79 |
